Cellular Immunity Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۷۲۱-۷۳۵ از ۹٬۹۲۴ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Tolga Bozkurtمشاهده پروفایل

دانشیار

Imperial College LondonUnited Kingdom

Dr. Tolga Bozkurt is an Associate Professor in Molecular Plant-Microbe Interactions at Imperial College London’s Faculty of Natural Sciences, Department of Life Sciences. His research focuses on plant immunity mechanisms against pathogens, particularly autophagy modulation, NLR immune receptor networks, and chloroplast dynamics at infection sites. He founded the Bozkurt Research Group in 2014, which develops innovative methodologies like AI-driven protein modeling (AlphaFold2-multimer) and electrochemical sensors to study plant-pathogen interactions. Key affiliations include the Agri Futures Lab, CRUK Convergence Science Centre, and the Fungal Science Network. His work bridges traditional cell biology with cutting-edge technologies to enhance crop resilience and agricultural sustainability. He co-founded Resurrect Bio to commercialize disease-resistant crop solutions derived from his lab’s discoveries. Research interests include pathogen effector subversion of autophagy and membrane trafficking, bioengineering synthetic immune receptors, and understanding chloroplast positioning during immune responses. His lab studies model systems like Phytophthora infestans and Nicotiana benthamiana to uncover mechanisms of host-pathogen co-evolution. Notable grants include BBSRC funding for engineering plant immunity. His publications emphasize AI applications in protein structure prediction and cross-kingdom autophagy modulation.

پروفایل رسمی دانشگاه

Mariagrazia Pizzaمشاهده پروفایل

استاد

Imperial College LondonUnited Kingdom

Mariagrazia Pizza is a Professor of Microbiology and Co-director of the Centre of Bacterial Resistance Biology (CBRB) at Imperial College London's Faculty of Natural Sciences. She previously held roles as Senior Scientific Director of Bacterial Vaccines at GSK and Head of Research at GVGH. Her expertise spans over 30 years in vaccine development, with a focus on bacterial pathogens such as Neisseria meningitidis and Klebsiella pneumoniae. She pioneered the MenB vaccine (4CMenB), which has been licensed in over 50 countries and protects infants against meningococcal B disease. Her current research targets Klebsiella pneumoniae, a multidrug-resistant pathogen, aiming to identify novel vaccine candidates and virulence factors. Education and Career: Extensive experience in academia and industry, including leadership roles in global vaccine initiatives. Research Interests: Vaccine development, bacterial pathogenesis, antimicrobial resistance, and reverse vaccinology approaches. Key projects include MenB vaccine efficacy, cross-protection mechanisms, and Klebsiella virulence factors. She has received prestigious awards including the MahnHoon Award 2023 and is an elected member of EMBO, the European Academy of Microbiology, and Academia Europaea. With over 250 publications and 70 patents, she contributes to global health initiatives through WHO advisory roles and the IUMS Bacteriology Division. Labs and Collaborations: Leads the CBRB, collaborating globally on vaccine research and antimicrobial resistance solutions.

پروفایل رسمی دانشگاه

Ellis Patrickمشاهده پروفایل

دانشیار

University of SydneyAustralia

Associate Professor Ellis Patrick is an applied statistician and bioinformatician affiliated with the University of Sydney's School of Mathematics and Statistics, the Westmead Institute for Medical Research, and the Sydney Precision Data Science Centre. His research focuses on developing bioinformatics tools to analyze high-dimensional biomedical data, with applications in disease treatment, precision medicine, and understanding molecular drivers of conditions like Alzheimer’s, MS, and cancer. He holds a PhD from the University of Sydney and postdoctoral experience at Harvard Medical School and The Broad Institute. Education: PhD in statistical bioinformatics from the University of Sydney. Postdoctoral training included joint appointments at Brigham and Women’s Hospital, Harvard Medical School, and The Broad Institute of MIT and Harvard. Research Interests: Specializes in statistical bioinformatics, spatial omics, and high-dimensional data analysis, with emphasis on translational research in infectious diseases, organ transplantation, cardiovascular disorders, neurodegeneration, and oncology. His work combines computational methods with clinical data to uncover disease mechanisms and improve therapeutic strategies. Grants & Collaborations: Recent grants include PrecisionGO (MRFF-funded), White matter lesion transcriptomics (National MS Society), and studies on coronary artery disease and graft failure prediction. Collaborates widely with medical researchers, leveraging interdisciplinary teams to tackle complex health challenges. Labs & Teams: Leads the Bioinformatics Cluster at the Sydney Precision Data Science Centre, integrating computational and experimental approaches to advance precision health initiatives.

پروفایل رسمی دانشگاه

Scott A Guelcherمشاهده پروفایل

استاد

Vanderbilt UniversityUnited States

Scott A. Guelcher is a Professor of Chemical and Biomolecular Engineering, Biomedical Engineering, and Pathology, Microbiology and Immunology at Vanderbilt University's School of Engineering. His research focuses on developing polymeric biomaterials for bone tissue engineering, including injectable scaffolds, biodegradable composites, and drug delivery systems. His work addresses clinical needs in orthopedics, such as bone graft alternatives and fracture fixation devices. Education: PhD in Chemical Engineering from Carnegie Mellon University (Carnegie Mellon), M.S. from University of Pittsburgh, and B.S. from Virginia Tech. Research interests include designing biomaterials with tunable mechanical/biological properties, ex vivo bone tissue engineering in perfusion bioreactors, and ROS-degradable materials for wound healing. Collaborations include Virginia Tech and allograft bone companies. Industrial experience includes Eastman Chemical Company and Bayer Corporation's Polyurethanes Division. Key contributions include injectable polyurethane foams for bone repair, biodegradable fracture fixation devices, and 3D-printed bone models for tumor-bone disease studies. His work integrates materials science, biomedical engineering, and clinical applications to advance regenerative medicine.

پروفایل رسمی دانشگاه

Deborah Dunn-Waltersمشاهده پروفایل

استاد

University of SurreyUnited Kingdom

Deborah Dunn-Walters is a Professor of Immunology and Associate Dean for Research and Innovation at the University of Surrey. She leads the Department of Biochemistry and Physiology within the School of Biosciences, Faculty of Health and Medical Sciences. Her research focuses on B cell development, immunosenescence, and antibody repertoire dynamics, with particular emphasis on responses to SARS-CoV-2 and other respiratory infections. Dunn-Walters pioneered tools like BRepertoire and sciCSR for analyzing immune repertoires using single-cell and computational methods. She chairs international B cell conferences and collaborates globally. Education includes a BSc (Hons I) and PhD, details unspecified. Her work integrates systems immunology approaches to understand age-related changes in humoral immunity, aiming to improve vaccine efficacy and combat pandemic threats. Awards include Fellowship of the Academy of Medical Sciences (2025). Research interests span regulatory B cells, metabolic regulation (e.g., thioredoxin’s role), tumor-infiltrating B lymphocytes, and antibody diversity in health/disease. She leads a lab developing novel methods for immune repertoire analysis, including web tools like VCAb for antibody structure exploration. Grants and advising are central to her role as Associate Dean, though specific grants aren’t listed. She oversees research innovation strategies and supports interdisciplinary collaborations. Her lab’s work has implications for cancer immunology, autoimmune disease, and infectious disease management.

پروفایل رسمی دانشگاه

Jun Allardمشاهده پروفایل

استاد

University of California, IrvineUnited States

Jun Allard is a Professor at the University of California, Irvine, with joint appointments in the Department of Mathematics and Department of Physics and Astronomy. He is affiliated with the Center for Complex Biological Systems and the NSF-Simons Center for Multiscale Cell Fate Research. Education includes: Ph.D. Applied Mathematics, University of British Columbia (2011) M.Sc. Physics, Dalhousie University (2007) B.Sc. Mathematical Physics, Queen's University (2005) His research specializes in mathematical and computational modeling of cellular and biomolecular mechanics. Key interests include how cells utilize force, space, and time to solve problems, with applications in immune cell signaling, cytoskeletal dynamics, and intracellular transport. His work combines theoretical models with experimental collaborations to uncover fundamental biological mechanisms. Recent publications (2021-2025) predominantly focus on computational approaches to cellular processes, including molecular transport mechanisms, immune receptor dynamics, and cytoskeletal organization. These studies employ advanced stochastic modeling, biophysical simulations, and quantitative experimental methods to reveal principles governing cellular behavior. Scientific awards include: UCI Chancellor's Award for Distinguished Fostering of Undergraduate Research (2015) Emerging Diversity Scholar, National Center for Institutional Diversity (2016) Honorable Mention, NSF Graduate Research Fellowship (2012) He has advised over 12 doctoral students and leads the Allard Lab, which develops computational models for cell mechanics. Major grants include NSF awards for research on molecular-tether reactions (DMS-2052668), nanoparticle adhesion (CBET-1929565), and multiscale cell fate (DMS-1763272). The lab collaborates internationally with experimental groups and participates in interdisciplinary initiatives including the Chemical and Materials Physics program.

پروفایل رسمی دانشگاه

Albert Guskovمشاهده پروفایل

دانشیار

University of GroningenNetherlands

Albert Guskov is an Associate Professor at the University of Groningen's Faculty of Science and Engineering, leading the Biomolecular X-ray Crystallography Lab. He holds an honorary professorship at Moscow Institute of Physics and Technology and has received numerous awards, including the Medal of Excellence (2021) and NWO VIDI Grant (2015). His research focuses on membrane transporters, protein translation in pathogenic fungi, and structural biology using X-ray crystallography and cryo-EM. He has published over 50 peer-reviewed papers with >3,800 citations. Education: PhD in Chemistry (Free University Berlin, 2009), Dipl. Chem. in Medicinal Chemistry (Summa cum laude). Research Interests: Structural characterization of SLC1 transporters, bacterial metallohomeostasis, and fungal ribosome mechanisms. His lab has pioneered studies on the structural basis of episodic ataxia 6 and Candida albicans ribosome resistance to cycloheximide. He actively contributes to educational standards as Chair of the Biomolecular Sciences MSc Program Committee.

پروفایل رسمی دانشگاه

Francesco Dell'Accioمشاهده پروفایل

استاد

Queen Mary University of LondonUnited Kingdom

Professor Francesco Dell’Accio is a clinical rheumatologist and scientist at Queen Mary University of London, affiliated with the William Harvey Research Institute (Faculty of Medicine and Dentistry) and the Department of Experimental Medicine & Rheumatology. His research focuses on regenerative medicine and osteoarthritis, with a particular emphasis on understanding molecular mechanisms underlying cartilage repair and identifying therapeutic targets. He leads a multidisciplinary team investigating signaling pathways in cartilage injury and disease progression, aiming to develop pharmacological interventions to restore cartilage integrity and alleviate osteoarthritis pain. His research group includes senior members like Prof. Shafaq Sikandar and Dr. Suzanne Eldridge, as well as postdoctoral researchers and PhD students such as Aida Barawi, Sabah Bharde, and Melody Deniz. Collaborations span institutions like Oxford, Harvard, and international partners in Germany and Scotland. Funding sources include Versus Arthritis, the Medical Research Council, and industry partners like UCB. Key research themes include the role of agrin in cartilage regeneration, ROR2 signaling blockade for osteoarthritis therapy, and neutrophil-derived extracellular vesicles in joint protection. His work integrates molecular biology, preclinical models, and clinical translation, with a focus on pain mechanisms and disease-modifying osteoarthritis drugs (DMOADs). The ReGen Lab (@TheReGenLab) is at the forefront of developing novel strategies to address cartilage defects and arthritis-related pain.

پروفایل رسمی دانشگاه

Mike Wiltonمشاهده پروفایل

استاد آموزشی

University of California , Santa Barbara (UCSB)United States

Dr. Mike Wilton is an Associate Teaching Professor and Associate Dean of the Division of Undergraduate Education at the University of California, Santa Barbara (UCSB), within the Department of Molecular, Cellular, and Developmental Biology. He holds a BS in Biology from Queen's University and a PhD in Cell and Systems Biology from the University of Toronto. His postdoctoral work at the University of Calgary focused on bacterial virulence strategies in Pseudomonas aeruginosa. His research spans two key areas: microbiology (bacterial pathogenesis and host immune interactions) and biology education, emphasizing peer mentorship and active learning. He investigates how educational interventions like structured curricula and peer mentorship impact student success, retention, and identity formation in STEM fields. Notably, his work has shown that peer-mentored programs improve academic performance and persistence, particularly for underrepresented groups. Dr. Wilton’s microbiology publications explore mechanisms by which bacteria evade immune responses, including studies on Pseudomonas aeruginosa’s defense against neutrophil extracellular traps and type VI secretion systems. His educational research has informed scalable interventions to enhance inclusivity and diversity in undergraduate STEM education. His advising and grants focus on implementing evidence-based practices to foster student engagement and equity. Collaborations extend to interdisciplinary teams in both microbiology and education research, though specific grant details are not detailed here.

پروفایل رسمی دانشگاه

Brooke Gardnerمشاهده پروفایل

استادیار

University of California , Santa Barbara (UCSB)United States

Brooke Gardner is an Assistant Professor in the Department of Molecular, Cellular, and Developmental Biology at UC Santa Barbara. Her research focuses on peroxisome biogenesis and homeostasis, particularly investigating how organelle dysfunction contributes to aging-related diseases. She leads the Gardner Lab, which employs biochemistry, cell biology, and genetics to study peroxisome regulation. Dr. Gardner holds a BA from Middlebury College, a PhD from UCSF, and completed postdoctoral research at UC Berkeley. She joined UCSB in 2019 and is affiliated with the Center for Aging and Longevity Studies (CALS). Education: PhD in Biochemistry, UC San Francisco (Walter Lab, 201X) BA in Biochemistry, Middlebury College Miller Fellow, UC Berkeley (Martin Lab) Research Interests: Peroxisome biogenesis and degeneration Role of Pex proteins in organelle formation Impact of peroxisomal dysfunction on aging and metabolic disorders Mechanisms of protein translocation across peroxisomal membranes Lab Members and Advising: Graduate students: Bashir Ali, Soham Chowdhury, Milagros Esmerode, Nikki Jacobsen, Connor Sheedy Undergraduates: David Boehm, Sambhav Jain, Alexei Miller Lab Manager: Julien Bacal Labs & Affiliations: Gardner Lab, UC Santa Barbara Center for Aging and Longevity Studies (CALS) Neuroscience Research Institute

پروفایل رسمی دانشگاه

Hannah Carterمشاهده پروفایل

استاد

University of California, San DiegoUnited States

Dr. Hannah Carter is a Professor of Medicine at the University of California San Diego (UCSD), affiliated with the School of Medicine and the Department of Biomedical Informatics. She specializes in computational modeling of tumor genomics, focusing on how DNA mutations influence cellular processes and cancer development. Her research integrates high-dimensional genomic data to identify cancer drivers and improve precision medicine approaches. Education: MEng in Electrical and Computer Engineering (University of Louisville, 2004), PhD in Biomedical Engineering (Johns Hopkins University, 2012). Research interests include cancer genomics, bioinformatics tool development, and the application of network approaches to oncology. Key projects include NIH-funded studies on tumor mutation stratification and immune surveillance disruption in cancer. Publications span computational methods for variant analysis (e.g., CHASM toolkit) and mechanistic studies linking genomic changes to cellular behavior. Her work has been recognized through awards like the NIH Early Independence Award (2013) and the Azrieli Global Scholar distinction (2017). Labs and affiliations include the Division of Biomedical Informatics and Division of Medical Genetics at UCSD. She leads collaborative initiatives on genomic variation impacts in pancreatic beta cells and cancer-immune interactions.

پروفایل رسمی دانشگاه

Daniel Wangpraseurtمشاهده پروفایل

پژوهشگر

University of California, San DiegoUnited States

Dr. Daniel Wangpraseurt is an Associate Researcher at Scripps Institution of Oceanography, University of California, San Diego, where he leads the Coral Reef Ecophysiology and Engineering Lab. He joined Scripps in summer 2024 and co-founded Hybrid Reef Solutions, a startup developing sustainable coral reef protection technologies. Wangpraseurt serves as associate editor for Frontiers in Marine Science: Coral Reefs and sits on the Coral Restoration Consortium advisory board. His educational background includes: PhD from University of Technology Sydney, Australia MSc from Max Planck Institute for Marine Microbiology & Leibniz Center for Tropical Marine Ecology, Germany BSc from James Cook University, Australia Wangpraseurt's research bridges coral reef science, engineering, and biophysics with core interests in coral ecophysiology, restoration engineering, benthic photosynthesis, and blue technology. His work develops innovative tools for reef restoration while investigating fundamental coral physiological processes and optical properties. Analysis of his 2024-2025 publications reveals dominant themes in coral restoration technology development, including biomimetic settlement substrates, acoustic larval enrichment, and engineered biofilms. His optical research focuses on coral microstructure imaging via the Benthic Underwater Microscope (BUMP) and light-harvesting mechanisms across depth gradients. No specific scientific awards are mentioned in the source material. He directs the Coral Reef Ecophysiology and Engineering Lab and leads Hybrid Reef Solutions. His collaborative research includes NSF-BSF projects on Red Sea mesophotic corals and IntBIO grants integrating nanobiotechnologies for coral symbiosis studies. Wangpraseurt maintains active roles in the Coral Restoration Consortium advisory board and Frontiers in Marine Science editorial board, driving both technological innovation and scientific discourse in coral reef conservation.

پروفایل رسمی دانشگاه

Rachel Watsonمشاهده پروفایل

استاد

Nanyang Technological UniversitySingapore

Professor Rachel Watson is an Executive Director at A*STAR Skin Research Labs (SRL) and the Skin Research Institute of Singapore (SRIS). She holds adjunct roles as Chief Scientist at the National Skin Centre and Adjunct Professor at Lee Kong Chian School of Medicine, Nanyang Technological University. Her research focuses on skin aging mechanisms, extracellular matrix repair, and ethnic skin differences. With a BSc (Hons) and PhD from the University of Sheffield, her work addresses intrinsic/extrinsic aging, Asian skin biology, and therapeutic development. She leads collaborative programs involving 18+ researchers across dermatology, bioinformatics, and genomics. Research emphasizes menopause effects on skin biomechanics, UV-induced inflammation, and dietary interventions like omega-3 fatty acids. Methodologies include clinical trials, transcriptomics, proteomics, and advanced imaging. Her lab team comprises 9 staff scientists and research officers. Key collaborations include Johns Hopkins Dermatology, University of Manchester, and multiple A*STAR institutes. Publications span 1997–2024, focusing on retinoid therapies, photoprotection strategies, and ethnic skin variability. Her work bridges fundamental research with clinical applications, addressing Singapore's aging population challenges and multi-ethnic healthcare needs.

پروفایل رسمی دانشگاه

Mārtiņš Vaivadsمشاهده پروفایل

استادیار

Riga Stradins UniversityLatvia

Mārtiņš Vaivads is an Assistant Professor at the Department of Morphology, Institute of Anatomy and Anthropology, Faculty of Medicine, Riga Stradins University. He also serves as Deputy Vice-Dean for International Students, reflecting his administrative engagement alongside academic responsibilities. His research centers on craniofacial development and anomalies, particularly non-syndromic cleft lip and palate. He investigates the molecular and genetic underpinnings of these conditions, focusing on homeobox genes, signaling pathways (SHH, WNT), and tissue-level changes involving inflammation, immunomodulation, and regeneration. His work contributes to the UN Sustainable Development Goal 3 (Good Health and Well-being) through fundamental medical research. The recent publications (2017–2025) highlight a consistent focus on immunohistochemical analysis of candidate genes and proteins in cleft-affected tissues. Key themes include the expression of BARX1, DLX4, FOXE1, HOXB3, MSX2, SOX3, PAX7, SHH, and WNT proteins, as well as factors involved in tissue protection and regeneration such as HSP60 and BMP2. His work bridges developmental biology, molecular genetics, and clinical anatomy. He leads a PhD-level research project titled 'Investigation of genes and gene proteins in cleft affected tissue' and actively participates in broader institutional research on craniofacial anomalies. He regularly presents findings at conferences, including oral and poster presentations, and engages in peer review for journals like Tissue and Cell . Latvian Council of Science Expert, Field of Science 3.1 Basic Medicine (2024–2027) He advises doctoral candidates and collaborates with researchers such as Professor Maija Pilmane and Professor Ingrida Akota. His research is supported by RSU internal grants and PhD project funding. He is part of a collaborative network studying tissue remodeling and inflammation in craniofacial anomalies, contributing to a multidisciplinary team that includes experts in histology, immunology, and maxillofacial surgery.

پروفایل رسمی دانشگاه

Wendell Limمشاهده پروفایل

استاد

University of California, San FranciscoUnited States

Wendell Lim is a Professor in the Department of Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF), School of Medicine. He is a leading figure in synthetic biology and cellular engineering, directing the Lim Lab, which focuses on reprogramming immune cells for precision cancer immunotherapies. His research integrates synthetic biology, immunology, and systems biology to design novel cell-based therapeutics. University: University of California San Francisco School: School of Medicine Department: Department of Cellular and Molecular Pharmacology Academic Rank: Professor Email: wendell.lim@ucsf.edu Dr. Lim's research interests center on synthetic biology, T cell engineering, cell signaling, and programmable cell therapies. His lab pioneers technologies such as synNotch and CAR-T systems that enable precise control over immune cell behavior, allowing for spatial and temporal regulation of therapeutic activity. His work aims to overcome challenges in cancer heterogeneity, specificity, and persistence. The recent publications of Dr. Lim reflect a strong trend toward engineering smart cell therapeutics, particularly through modular receptor systems, synthetic cytokine circuits, and logic-gated T cells. These works span disciplines including immunology, cancer biology, protein engineering, and regenerative medicine, emphasizing the development of next-generation, conditionally activated immunotherapies with enhanced safety and efficacy. Dr. Lim has received widespread recognition for his contributions to synthetic biology and immunoengineering. His work is frequently published in top-tier journals such as Science , Nature , and Cell , and he is a sought-after speaker and collaborator in the field. He mentors a large group of students, postdoctoral researchers, and collaborators, many of whom are co-authors on his publications. His lab has secured significant funding to support research in engineered cell therapies, synthetic signaling circuits, and translational applications in oncology and autoimmunity. The Lim Lab also develops educational tools and frameworks for teaching synthetic biology concepts. Dr. Lim leads interdisciplinary teams working on synthetic morphogen systems, degron-based control mechanisms, and multicellular patterning, aiming to build foundational platforms for programmable tissues and intelligent cell-based medicines.

پروفایل رسمی دانشگاه